The TB-500 dosage protocol follows a two-phase structure
(ACTIVATOR): Aqua (Water), Glycerin, Tripeptide-29, Tripeptide-1, Myristoyl Nonapeptide-3, Trifluoroacetyl Tripeptide-2, Acetyl Tetrapeptide-2, Sodium Hyaluronate Crosspolymer, Glycogen, Propanediol, Pentylene Glycol, Dextran, Dimethyl Isosorbide, Ethoxydiglycol, Isoceteth-20, Leuconostoc/Radish Root Ferment Filtrate, Caprylyl Glycol, Ethylhexylglycerin, Phenoxyethanol, Chlorphenesin
Beigi Harchegani A, Dahan H, Tahmasbpour E, Bakhtiari Kaboutaraki H, Shahriary A
W badaniach in vitro oraz ex vivo (na modelach komrkowych i tkankowych) substancja ta wchodzi w interakcje gwnie z: Szlakami sygnaowymi fibroblastw , gdzie stymuluje ekspresj genw odpowiedzialnych za syntez biaek strukturalnych macierzy zewntrzkomrkowej (ECM)
Further studies in the 2000s, (7) suggested that the GHK-Cu peptide hosts the potential to not only stimulate the collagen synthesis but also stimulate the production of tissue inhibitors, TIMP-1 and TIMP-2
Basic physiology of the blood-brain barrier in health and disease: a brief overview